Literature DB >> 8689689

Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities.

A Schedl1, A Ross, M Lee, D Engelkamp, P Rashbass, V van Heyningen, N D Hastie.   

Abstract

Aniridia in man and Small eye in mice are semidominant developmental disorders caused by mutations within the paired box gene PAX6. Whereas heterozygotes suffer from iris hypoplasia, homozygous mice lack eyes and nasal cavities and exhibit brain abnormalities. To investigate the role of gene dosage in more detail, we have generated yeast artificial chromosome transgenic mice carrying the human PAX6 locus. When crossed onto the Small eye background, the transgene rescues the mutant phenotype. Strikingly, mice carrying multiple copies on a wild-type background show specific developmental abnormalities of the eye, but not of other tissues expressing the gene. Thus, at least five different eye phenotypes are associated with changes in PAX6 expression. We provide evidence that not only reduced, but also increased levels of transcriptional regulators can cause developmental defects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689689     DOI: 10.1016/s0092-8674(00)80078-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  140 in total

1.  A 7.5 Mb sequence-ready PAC contig and gene expression map of human chromosome 11p13-p14.1.

Authors:  B Gawin; A Niederführ; N Schumacher; H Hummerich; P F Little; M Gessler
Journal:  Genome Res       Date:  1999-11       Impact factor: 9.043

2.  Ophthalmology in the post-genomic era.

Authors:  G C Black; M E Boulton; P N Bishop; D McLeod
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

3.  Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye.

Authors:  R Ashery-Padan; T Marquardt; X Zhou; P Gruss
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

4.  Activation of the human PAX6 gene through the exon 1 enhancer by transcription factors SEF and Sp1.

Authors:  J B Zheng; Y H Zhou; T Maity; W S Liao; G F Saunders
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

5.  Crystal structure of the human Pax6 paired domain-DNA complex reveals specific roles for the linker region and carboxy-terminal subdomain in DNA binding.

Authors:  H E Xu; M A Rould; W Xu; J A Epstein; R L Maas; C O Pabo
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

6.  PAX6 expression in the developing human eye.

Authors:  S Nishina; S Kohsaka; Y Yamaguchi; H Handa; A Kawakami; H Fujisawa; N Azuma
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

7.  Transfection of primary embryonic chicken retinal cells using cationic lipid.

Authors:  Yi-Wen Hsieh; Xian-Jie Yang
Journal:  Methods Mol Biol       Date:  2012

8.  Pax6 organizes the anterior eye segment by guiding two distinct neural crest waves.

Authors:  Masanari Takamiya; Johannes Stegmaier; Andrei Yu Kobitski; Benjamin Schott; Benjamin D Weger; Dimitra Margariti; Angel R Cereceda Delgado; Victor Gourain; Tim Scherr; Lixin Yang; Sebastian Sorge; Jens C Otte; Volker Hartmann; Jos van Wezel; Rainer Stotzka; Thomas Reinhard; Günther Schlunck; Thomas Dickmeis; Sepand Rastegar; Ralf Mikut; Gerd Ulrich Nienhaus; Uwe Strähle
Journal:  PLoS Genet       Date:  2020-06-17       Impact factor: 5.917

9.  Xenopus pax6 mutants affect eye development and other organ systems, and have phenotypic similarities to human aniridia patients.

Authors:  Takuya Nakayama; Marilyn Fisher; Keisuke Nakajima; Akinleye O Odeleye; Keith B Zimmerman; Margaret B Fish; Yoshio Yaoita; Jena L Chojnowski; James D Lauderdale; Peter A Netland; Robert M Grainger
Journal:  Dev Biol       Date:  2015-02-25       Impact factor: 3.582

Review 10.  Signaling and Gene Regulatory Networks in Mammalian Lens Development.

Authors:  Ales Cvekl; Xin Zhang
Journal:  Trends Genet       Date:  2017-08-31       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.